StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

CNBX Pharmaceuticals's gross margin for the twelve months ending Feb 28, 2018 was 100.0%. For fiscal 2017 it was 100.0%, against 100.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2017Aug 31, 2017100.0%+0.0
FY2016Aug 31, 2016100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2024CQ1 2024Feb 29, 202484.7%−15.3
Q1 FY2019CQ4 2018Nov 30, 2018100.0%+0.0
Q2 FY2018CQ1 2018Feb 28, 2018100.0%+0.0
Q1 FY2018CQ4 2017Nov 30, 2017100.0%+0.0
Q4 FY2017CQ3 2017Aug 31, 2017100.0%–
Q3 FY2017CQ2 2017May 31, 2017100.0%–
Q2 FY2017CQ1 2017Feb 28, 2017100.0%–
Q4 FY2016CQ3 2016Aug 31, 2016100.0%–

More CNBX Pharmaceuticals figures

See a number that looks wrong?